Search results
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena via Yahoo Finance· 6 days agoPalatin Technologies has commenced a Phase II clinical trial of breatelanotide, a melanocortin 4...
Proportion of Americans with poor diets decreased in last 2 decades, study finds
Scripps News via AOL· 4 hours agoThe proportion of adults with poor diets decreased from 48.8% to 36.7% over 20 years, but the...
Gateway - Quartz
Quartz· 7 hours agoJohnson & Johnson agreed this week to settle a multi-state case alleging it misled consumers about the safety of its talc...COVID-flu combo vaccine outperformed existing, stand alone vaccines ...
American diets improve, but remain poor for many, Tufts study says
United Press International via Yahoo News· 1 day agoPoor diet takes a toll on health. It's a major risk factor for obesity, type 2 diabetes,...
Metformin For Weight Loss: How Long Does It Take to Finally Work?
MediaFeed via AOL· 3 days agoWhen you’re motivated to lose weight and taking steps to make it happen, you want results — fast....
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal via Yahoo Finance· 2 days agoTheir Alzheimer’s drug, Leqembi, was approved by the Food and Drug Administration last year but ...
Novo’s blockbuster obesity drug Wegovy under fire in Denmark
Detroit News· 6 days agodrug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s blockbuster ...
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool via Yahoo Finance· 2 days agoThe catch is that Structure is still toward the beginning of its life as a biotech. It hasn't yet...
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool via Yahoo Finance· 4 days agoThat's understandable. The drugmaker is a leader in these areas,and its most recent medicines,...
Gateway - Quartz
Quartz· 1 day agoThe world’s largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties “created a high risk of consumer confusion and& ...
